What happened: Novo Nordisk has filed a lawsuit against Hims & Hers, claiming their weight-loss drugs infringe on its patents. Hims & Hers has described the legal action as a 'blatant attack.'
Why it matters:
- The case could affect competition and pricing in the weight-loss drug market.
- Patients seeking weight-loss treatments might face limited options depending on the lawsuit's outcome.
MNN Take: Patent disputes like this are common in the pharmaceutical industry as companies protect their innovations. The legal process will determine if Hims & Hers' products violate Novo Nordisk's patents.
Sources: BBC Business